ArticleProceedings of the National Academy of Sciences of the United States of America2021

Engineering genetic devices for in vivo control of therapeutic T cell activity triggered by the dietary molecule resveratrol.

Linfeng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.